Christina Farr is a technology and health reporter for CNBC.com in San Francisco. She most recently was a senior writer at Fast Company, covering biotech and health-tech for digital and print, and an Apple reporter at Reuters News. She hails from London, UK and is a graduate of Stanford's School of Journalism. Reach her on Twitter (@chrissyfarr).
DNA Friend might be a joke. But for DNA testing companies, it hits very close to home.
Stanford's researchers talked about the study at the American College of Cardiology conference in New Orleans.
Health experts say it's a smart move for Amazon, as it gets deeper into the health and medical space.
Signify Health acquired TAV Health, marking a rare acquisition of a start-up that is focusing on social determinants of health.
Walmart published an extensive case study this week on its efforts to improve health care for its employees.
Amazon, J.P. Morgan and Berkshire Hathaway are building a team to fix health care for their employees. Here's what we know.
Eric Topol just released a new book examining the role of artificial intelligence in medicine.
23andMe is adding a report to its health and ancestry DNA test for type 2 diabetes. That's a huge market opportunity as 1 in 3 people are at risk for developing the disease. More than 30 million people in the U.S. alone have diabetes.
Juul created a new enterprise markets team to strike deals with health plans, providers, self-insured employers, as well as public sector.
Tesla and its CEO face dozens of investigations and lawsuits from government agencies, former employees, shareholders and more.
Google unveiled its streaming game service called Stadia on Tuesday which won't require people to buy expensive game consoles or computers to play the latest video games.
AMD will power Stadia's graphics rendering in the cloud, Google announced at an event Tuesday.
Lyft has set an indicative IPO price range of $62 to $68 per share and is set to price the IPO on March 28.
Get the best of CNBC in your inbox
Data also provided by 
